🎯 3 free searches remaining

Back to Search
CSE

C21 Investments Inc.

CXXI.CNHealthcareDrug Manufacturers - Specialty & Generic
Current Price
$0.40
Today's Change
-1.23%
Market Cap
$47.22M
Volume
29.13K

💡 Quick Take

C21 Investments Inc. is an integrated cannabis company focused on cultivating, processing, and selling cannabis and hemp-derived products in the U.S. Key strengths include a solid gross margin of 38.2% and a reasonable current ratio of 1.32, indicating decent liquidity. However, concerns arise from a negative net margin of -7.5% and low returns on equity and assets, suggesting profitability challenges. The company's market cap of $47.22M, combined with a declining stock price, raises questions about its valuation despite its operational strengths.

Based on 28 data points⚠️Not financial advice

📊 Key Metrics

52 Week High$0.68
52 Week Low$0.15
Avg Volume50.00K
Beta2.05
Shares Outstanding118.04M

🔥 Valuation

Market Cap$47.22M
Enterprise Value$55.74M
P/E Ratio-10.00
EV/EBITDAN/A
Dividend Yield0.00%

Loading financial metrics...

🚩 Red Flags

🟠

Significant Losses

Company posted a loss of $-3.4M over the last year, representing 10.3% of revenue.

🟠

High Debt Load

Debt of $10.9M is 4.5x the company's cash position of $2.4M.

🌟 Opportunities

📊

No significant opportunities identified

Based on current financial metrics

Want the Complete Picture?

Valuation, risk assessment, competitive positioning, and key insights — all in one report.

Free users:3 reports remaining

Recent Developments

Loading news...